Jove
Visualize
联系我们

相关概念视频

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

611
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
611
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

791
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
791
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

863
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
863
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

808
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
808

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Relative entropy as a biomarker for vagus nerve stimulation response in epilepsy: Insights from intracerebral electroencephalography.

Epilepsia open·2026
Same author

Real-world effectiveness of cenobamate in drug-resistant and ultra-refractory epilepsy: A multicenter study.

Epilepsia open·2026
Same author

Oral Care in Patients With Invasive Airway Management in the ICU: A Prospective Observational Study.

Critical care nursing quarterly·2026
Same author

Intracranial electroencephalographic connectivity analysis to localize epileptogenic networks: Systematic review and meta-analysis from ILAE Epilepsy Surgery Networks Task Force.

Epilepsia·2026
Same author

Timing for Starting Antiseizure Medication Withdrawal After Epilepsy Surgery in Adults.

Neurology·2026
Same author

Network hubs supporting memory encoding: Implications for cognitive preservation in epilepsy surgery.

Epilepsia·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 9, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.4K

超耐火性:新描述的实体.

Jan Vinklárek1, Petra Búřilová2, Mojdeh Raouf Zadeh3

  • 1Brno Epilepsy Center, Member of European Reference Network (ERN)-EpiCARE, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Epilepsia open
|December 9, 2025
PubMed
概括

超耐药性 (URE) 是一种严重的疾病,患者在多次治疗中失败. 对于这种具有挑战性的形式,迫切需要新的治疗策略.

关键词:
抗发作药物 抗发作药物药物耐药性 - 抗药性神经刺激的神经刺激.切除性脑外科手术是什么?超耐火性 - 超耐火性

更多相关视频

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.8K
Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
05:54

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

17.9K

相关实验视频

Last Updated: Jan 9, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.4K
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.8K
Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
05:54

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

17.9K

科学领域:

  • 神经学 神经学
  • 发病学 (Epileptology) 是一个专业的学科.

背景情况:

  • 耐药性 (DRE) 影响了大约30%的患者.
  • 超耐药性 (URE) 是一种严重的亚型,其特点是≥6种治疗策略的失败.
  • 在专门的中心中,URE构成了重大的治疗挑战.

研究的目的:

  • 分析URE患者的人口和临床数据.
  • 描述URE中的治疗场景和结果.

主要方法:

  • 具有前性后续的回顾性队列研究.
  • 在布尔诺中心 (2017-2023) 管理的成年URE患者的分析.
  • 通过医疗记录和结构化的电话采访收集数据.

主要成果:

  • 在1034名被审查的患者中,62名患者 (6%) 符合URE标准.
  • 平均发作发作时间为9岁,平均评估年龄为35岁.
  • 高发作负担 (中位数为9次/月),42%,>20次/月.
  • 结构性病因最常见 (47%);92%接受多式疗法 (ASM,手术,神经刺激).

结论:

  • 尿尿急症是一种极端的治疗挑战,具有很高的负担.
  • 治疗反应有限强调了需要新的治疗策略.
  • 由于大量未满足的医疗需求,对URE的进一步研究至关重要.